Corrigendum to ‘Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease’ EBioMedicine 47 (2019) 446–456

In this article, a re-analysis of the raw data has been conducted, which means that some conclusions presented in the paper have changed. The authors have written a Corrigendum which is appended (Appendix 1). In the interests of transparency, they have included de-identified data from the original article in Appendix 2. Download .docx (.54 MB) Help with docx files Download .xlsx (.01 MB) Help with xlsx files Senolytics decrease senescent cells...